HSA reviewing Avandia
HSA reviewing Avandia
SINGAPORE’S Health Sciences Authority (HSA) is reviewing the benefits and risks associated with using Avandia, the most popular drug used in the treatment of diabetes here. A spokesman for the agency said it has been closely monitoring developments related to the drug in the United States.
Read more on Straits Times
Related posts:
- Fero Industries Comments On Recent FDA Advisory Panel Recommendation On Avandia(R)
- Aggressive diabetes treatments no help to heart
- Alimera Sciences provides new data from Iluvien Phase 3 FAME clinical trials for DME
- Connecticut’s Drug War is a Bust
- InNexus Announces Discovery Of Novel Protein For AMD Eye Disorder - Will Bypass Needles With Topical Application